✦ LIBER ✦

Examination of the MASH1 gene in patients with Parkinson’s disease

✍ Scribed by Hao Deng; Huarong Yang; Weidong Le; Xiong Deng; Hongbo Xu; Wei Xiong; Shaihong Zhu; Wenjie Xie; Zhi Song; Joseph Jankovic

Book ID: 116299794
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 155 KB
Volume: 392
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2010.01.061

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Examination of the MSX1 gene in patients

Examination of the MSX1 gene in patients with Parkinson’s disease

✍ H. Deng; S. H. Zhu; W. D. Le; H. R. Yang; H. W. Lv; H. B. Xu; W. J. Xie; J. Jank 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Decreased NURR1 gene expression in patie

Decreased NURR1 gene expression in patients with Parkinson's disease

✍ Weidong Le; Tianhong Pan; Maosheng Huang; Pingyi Xu; Wenjie Xie; Wen Zhu; Xiong 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB

Point mutation in the parkin gene on pat

Point mutation in the parkin gene on patients with Parkinson’s disease

✍ Wang Tao; Liang Zhihou; Sun Shenggang; Cao Xuebing; Peng Hai; Cao Fei; Liu Hongj 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 Chinese ⚖ 369 KB

ES143 Examination of specific cognitived

ES143 Examination of specific cognitivedisturbances in Parkinson's disease patients

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 111 KB

Genetic analysis of the NEUROG2 gene in

Genetic analysis of the NEUROG2 gene in patients with Parkinson's disease

✍ Sheng Deng; Hao Deng; Weidong Le; Hongbo Xu; Huarong Yang; Xiong Deng; Hongwei L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Glutathione-S-transferase-1 and interleu

Glutathione-S-transferase-1 and interleukin-1β gene polymorphisms in Japanese patients with Parkinson's disease

✍ Masataka Nishimura; Sadako Kuno; Ryuji Kaji; Katsuhito Yasuno; Hideshi Kawakami 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

## Abstract We studied genetic polymorphisms in the glutathione‐__S__‐transferase‐1 (GST‐1) gene region and the interleukin‐1β (IL‐1β) promoter region in patients with Parkinson's disease (PD, n = 361), as well as controls (n = 257). Although we have confirmed the previous results, in a larger samp